GSM (Genito-Urinary Syndrome of Menopause) is becoming an increasing concern for women worldwide. According to the North American Menopause Society, by the year 2025 the number of postmenopausal women is expected to rise to 1.1 billion, more than half of which will likely experience vulvovaginal symptoms that significantly impact their lifestyle, emotions and sex life.
The shift in hormones that occurs with menopause can cause the lining of the vagina to become thinner, drier, less elastic and inflamed. FemiLift rejuvenates the vaginal lining, increasing the thickness of the vaginal walls and restoring natural lubrication. The treatment reduces uncomfortable symptoms such as itching, burning and friction and helps improve sexual function.